---
figid: PMC4040351__nihms573273f2
figtitle: 'From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4040351
filename: nihms573273f2.jpg
figlink: /pmc/articles/PMC4040351/figure/F2/
number: F2
caption: 'A visual description of the signaling cascade is shown for the signal-receiving
  cell (i.e. the cell expressing the Notch receptor). Pathway inhibitors used include
  antibodies against NOTCH receptors and DLL ligands, γ-secretase complex inhibitors
  (GSI), and small peptides inhibiting formation of the transcriptional complex. Antibody-based
  treatments are shown in purple, GSI compounds in pink, peptide-based drugs in red.
  Potential epigenetic inhibitors (in green) can include BRD inhibitors like JQ1.
  HDAC: histone deacetylase, ICN1: intracellular part of NOTCH1, LSD1: lysine specific
  demethylase 1, SMRT: Silencing-Mediator for Retinoid/Thyroid hormone receptors,
  GSK3β: glycogen synthase kinase 3 beta, DNMAML1: dominant negative MAML1.'
papertitle: 'From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling.'
reftext: Panagiotis Ntziachristos, et al. Cancer Cell. ;25(3):318-334.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8980542
figid_alias: PMC4040351__F2
figtype: Figure
redirect_from: /figures/PMC4040351__F2
ndex: ceabced2-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4040351__nihms573273f2.html
  '@type': Dataset
  description: 'A visual description of the signaling cascade is shown for the signal-receiving
    cell (i.e. the cell expressing the Notch receptor). Pathway inhibitors used include
    antibodies against NOTCH receptors and DLL ligands, γ-secretase complex inhibitors
    (GSI), and small peptides inhibiting formation of the transcriptional complex.
    Antibody-based treatments are shown in purple, GSI compounds in pink, peptide-based
    drugs in red. Potential epigenetic inhibitors (in green) can include BRD inhibitors
    like JQ1. HDAC: histone deacetylase, ICN1: intracellular part of NOTCH1, LSD1:
    lysine specific demethylase 1, SMRT: Silencing-Mediator for Retinoid/Thyroid hormone
    receptors, GSK3β: glycogen synthase kinase 3 beta, DNMAML1: dominant negative
    MAML1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DLL4
  - DLL1
  - DLL3
  - JAG2
  - JAG1
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - NOTCH4
  - NOTCH1
  - NOTCH3
  - NOTCH2
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - KDM1A
  - NCOR2
  - CSHL1
  - RBPJ
  - SMPX
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - FBXW7
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - GSK3B
  - HES1
  - GATD3
  - HEY1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MYC
  - CCND1
  - BCL2
  - CCR7
  - RO4929097
  - Cancer
---
